Efficacy of pemafibrate in non-alcoholic fatty liver disease patients with dyslipidemia
Latest Information Update: 04 Feb 2021
Price :
$35 *
At a glance
- Drugs Pemafibrate (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 04 Feb 2021 New trial record